Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2015 2
2016 3
2017 9
2018 6
2019 1
2020 3
2021 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. J Clin Oncol. 2024 Mar 12:JCO2302474. doi: 10.1200/JCO.23.02474. Online ahead of print. J Clin Oncol. 2024. PMID: 38471061
Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients.
Strouse C, Mott SL, Smith BJ, Magalhaes-Silverman M, Farooq U, Zhan F, Jethava Y, Tricot G. Strouse C, et al. Among authors: jethava y. Bone Marrow Transplant. 2024 Jan;59(1):128-130. doi: 10.1038/s41409-023-02119-9. Epub 2023 Oct 10. Bone Marrow Transplant. 2024. PMID: 37816907 Free PMC article. No abstract available.
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.
Lesokhin AM, Tomasson MH, Arnulf B, Bahlis NJ, Miles Prince H, Niesvizky R, Rodrίguez-Otero P, Martinez-Lopez J, Koehne G, Touzeau C, Jethava Y, Quach H, Depaus J, Yokoyama H, Gabayan AE, Stevens DA, Nooka AK, Manier S, Raje N, Iida S, Raab MS, Searle E, Leip E, Sullivan ST, Conte U, Elmeliegy M, Czibere A, Viqueira A, Mohty M. Lesokhin AM, et al. Among authors: jethava y. Nat Med. 2023 Sep;29(9):2259-2267. doi: 10.1038/s41591-023-02528-9. Epub 2023 Aug 15. Nat Med. 2023. PMID: 37582952 Free PMC article. Clinical Trial.
A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction.
Nadiminti K, Langer K, Shabbir E, Hefazi M, Dozeman L, Jethava Y, Loeffler B, AlKhateeb HB, Litzow M, Patnaik M, Shah M, Hogan W, Farooq U, Silverman M, Mott SL. Nadiminti K, et al. Among authors: jethava y. Blood Cancer J. 2021 Nov 20;11(11):183. doi: 10.1038/s41408-021-00573-6. Blood Cancer J. 2021. PMID: 34802042 Free PMC article. Clinical Trial.
Minimal residual disease in multiple myeloma: are we there yet?
Devarakonda S, Jethava Y. Devarakonda S, et al. Among authors: jethava y. Int J Hematol Oncol. 2020 Nov 20;9(4):IJH29. doi: 10.2217/ijh-2020-0018. Int J Hematol Oncol. 2020. PMID: 33294170 Free PMC article. No abstract available.
Repurposing Anti-Cancer Drugs for COVID-19 Treatment.
Borcherding N, Jethava Y, Vikas P. Borcherding N, et al. Among authors: jethava y. Drug Des Devel Ther. 2020 Nov 18;14:5045-5058. doi: 10.2147/DDDT.S282252. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33239864 Free PMC article. Review.
Approach to a patient with cardiac amyloidosis.
Strouse C, Briasoulis A, Fonseca R, Jethava Y. Strouse C, et al. Among authors: jethava y. J Geriatr Cardiol. 2019 Jul;16(7):567-574. doi: 10.11909/j.issn.1671-5411.2019.07.010. J Geriatr Cardiol. 2019. PMID: 31447895 Free PMC article. No abstract available.
Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.
Gao M, Bai H, Jethava Y, Wu Y, Zhu Y, Yang Y, Xia J, Cao H, Franqui-Machin R, Nadiminti K, Thomas GS, Salama ME, Altevogt P, Bishop G, Tomasson M, Janz S, Shi J, Chen L, Frech I, Tricot G, Zhan F. Gao M, et al. Among authors: jethava y. J Natl Cancer Inst. 2020 May 1;112(5):507-515. doi: 10.1093/jnci/djz159. J Natl Cancer Inst. 2020. PMID: 31406992 Free PMC article.
28 results